Avita Medical, Inc. - Common Stock - fluxo de caixa trimestral (NASDAQ:RCEL)

Financials

Fluxo de caixa operacional -8.08 M-10.31 M-10.23 M-5.22 M-5.44 M-10.07 M -30.96 M Fluxo de caixa de investimento 2.47 M10.77 M7.02 M-5.34 M11 K2.04 M 3.73 M Fluxo de caixa de financiamento 1.02 M363 K559 K13.77 M248 K6.1 M 20.67 M Fluxo de caixa livre -8.08 M-10.31 M-10.75 M-6.17 M-4.83 M-10.09 M -31.85 M

Avita Medical, Inc. - Common Stock

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

RCEL

Financials

Avita Medical, Inc. - Common Stock

Notícias

AVITA Medical, Inc. (RCEL) Discusses Business Progress, Operational Changes and Sequential Revenue Growth Transcript

Lucro da Avita Medical veio abaixo das projeções por $0,06; receita supera estimativas

AVITA Medical obtém aprovação regulatória para RECELL GO na Austrália

AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript

Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock?

AVITA Medical: Why The BARDA Rally Changes Nothing (NASDAQ:RCEL)

AVITA Medical garante contrato de US$ 25,5 milhões com BARDA para preparação contra queimaduras

Avita Medical na conferência TD Cowen: crescimento e foco estratégico

Avita Medical at TD Cowen Conference: Growth and Strategic Focus

Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade

Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know

AVITA Medical, Inc. (RCEL) Discusses Financial Performance, Sales Strategy, and Reimbursement Progress Transcript